Location: | London |
---|---|
Salary: | £40,386 per annum, including London Weighting Allowance |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 7th December 2022 |
---|---|
Closes: | 18th December 2022 |
Job Ref: | 058708 |
Job description
Working under the supervision of Professor Anthony Dorling, in the Department of Inflammation Biology at KCL and Sakina Gooljar, Head of Advanced Therapy Production at the BRC Unit, Guy’s Hospital, the post holder with their experience and specialist knowledge in Good Manufacturing Practice (GMP) and immune cell culture will take responsibility for delivering ATMP manufacturing process for GAMECHANgER project. This is an early phase ATMP clinical trial.
Specifically, the post holder will be responsible for planning, directing and executing the production of T regulatory cell (Treg) product for participants enrolled in GAMECHANgER and will also be responsible for conduct immunomonitoring experiments on participant samples collected during the follow up phase of the trial. There will be a research assistant appointed to work alongside the successful applicant, that you will co-supervise with the PI. In this position you will develop strong working relationships with the chief investigator, senior trial manager, BRC staff, other academics, principle investigators, consultants, nursing staff, researchers and healthcare scientists.
This post will be offered on a fixed-term contract until 30th September 2024.
This is a full-time post - 100% full time equivalent
Type / Role:
Subject Area(s):
Location(s):